Literature DB >> 23147769

Periprocedural management and approach to bleeding in patients taking dabigatran.

Jeffrey I Weitz1, Daniel J Quinlan, John W Eikelboom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23147769     DOI： 10.1161/CIRCULATIONAHA.112.123224

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  28 in total

1.  Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions.

Authors:  James Douketis; Alan David Bell; John Eikelboom; Aaron Liew
Journal:  Can Fam Physician       Date:  2014-11       Impact factor: 3.275

Review 2.  Initiating and Managing Patients with Venous Thromboembolism on Anticoagulant Drugs: A Practical Overview.

Authors:  Raj S Kasthuri; Stephan Moll
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

Review 3.  Managing dentoalveolar surgical procedures in patients taking new oral anticoagulants.

Authors:  Stefano Sivolella; Marleen De Biagi; Giulia Brunello; Mario Berengo; Vittorio Pengo
Journal:  Odontology       Date:  2015-02-06       Impact factor: 2.634

Review 4.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 5.  The emergent reversal of coagulopathies encountered in neurosurgery and neurology: a technical note.

Authors:  Joshua Eric Medow; Matthew R Dierks; Eliot Williams; J Christopher Zacko
Journal:  Clin Med Res       Date:  2014-11-07

6.  Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.

Authors:  Jan Hendrik Schaefer; Wendy Leung; Limin Wu; Elizabeth M Van Cott; Josephine Lok; Michael Whalen; Klaus van Leyen; Arne Lauer; Joanne van Ryn; Eng H Lo; Christian Foerch
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-19       Impact factor: 6.200

7.  Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012.

Authors:  Paul L Hess; Michael J Mirro; Hans-Christoph Diener; John W Eikelboom; Sana M Al-Khatib; Elaine M Hylek; Hayden B Bosworth; Bernard J Gersh; Daniel E Singer; Greg Flaker; Jessica L Mega; Eric D Peterson; John S Rumsfeld; Benjamin A Steinberg; Ajay K Kakkar; Robert M Califf; Christopher B Granger
Journal:  Am Heart J       Date:  2014-04-24       Impact factor: 4.749

Review 8.  Safety of new oral anticoagulant drugs: a perspective.

Authors:  Juan Antonio Vílchez; Pilar Gallego; Gregory Y H Lip
Journal:  Ther Adv Drug Saf       Date:  2014-02

Review 9.  New oral pharmacotherapeutic agents for venous thromboprophylaxis after total hip arthroplasty.

Authors:  Garrett B Aikens; Jacob R Osmundson; Michael P Rivey
Journal:  World J Orthop       Date:  2014-07-18

Review 10.  Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.

Authors:  R Monroe Crawley; Rachel L Anderson
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.